Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
The University of Sydney · Royal North Shore Hospital · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
818
total citations
- FWCI
- 43.55
- Percentile
- 100%
- References
- 25
Citations per year
Authors
20- AMAlexander M. MenziesCorresponding
The University of Sydney, Royal North Shore Hospital, Melanoma Institute Australia
- DBDouglas B. Johnson
Vanderbilt University Medical Center
- SRSangeetha Ramanujam
The University of Sydney, Melanoma Institute Australia
- VAVictoria Atkinson
Greenslopes Private Hospital, Princess Alexandra Hospital
- AWAnnie Wong
Peter MacCallum Cancer Centre
Topics & keywords
Topics
Keywords
- Medicine
- Ipilimumab
- Immunosuppression
- Polymyalgia rheumatica
- Internal medicine
- Adverse effect
- Rheumatoid arthritis
- Melanoma
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.